Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin
Journal Title: The AAPS Journal - Year 2005, Vol 7, Issue 4
Abstract
Cutaneous drug reactions (CDRs) are the most commonly reported adverse drug reactions. These reactions can range from mildly discomforting to life threatening. CDRs can arise either from immunological or nonimmunological mechanisms, though the preponderance of evidence suggests an important role for immunological responses. Some cutaneous eruptions appear shortly after drug intake, while others are not manifested until 7 to 10 days after initiation of therapy and are consistent with delayed-type hypersensitivity. This review discusses critical steps in the initiation of delayed-type hypersensitivity reactions in the skin, which include protein haptenation, dendritic cell activation/migration and T-cell propagation. Recently, an alternative mechanism of drug presentation has been postulated that does not require bioactivation of the parent drug or antigen processing to elicit a drug-specific T-cell response. This review also discusses the role of various immune-mediators, such as cytokines, nitric oxide, and reactive oxygen species, in the development of delayed-type drug hypersensitivity reactions in skin. As keratinocytes have been shown to play a crucial role in the initiation and propagation of cutaneous immune responses, we also discuss the means by which these cells may initiate or modulate CDRs.
Authors and Affiliations
Sanjoy Roychowdhury, Craig K. Svensson
Keywords
Related Articles
- EP ID EP681905
- DOI 10.1208/aapsj070480
- Views 81
- Downloads 0
Quantitative Targeted Proteomics for Membrane Transporter Proteins: Method and Application
Although global proteomics has shown promise for discovery of many new proteins, biomarkers, protein modifications, and polymorphisms, targeted proteomics is emerging in the proteomics research field as a complement to u...
Effects of obesity on the pharmacodynamics of nitroglycerin in conscious rats
Literature reports have suggested that hemodynamic response toward organic nitrates may be reduced in obese patients, but this effect has not been studied. We compared the mean arterial pressure (MAP) responses toward si...
Clinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug Administration
The online version of this article (doi:10.1208/s12248-015-9782-0) contains supplementary material, which is available to authorized users.
A simultaneous assessment of CYP3A4 metabolism and induction in the DPX-2 cell line
The DPX-2 cell line, a derivative of HepG2 cells, harbors human PXR and a luciferase-linked CYP3A4 promoter. These cells were used in a panel of cell-based assays for a parallel assessment of CYP3A4 induction, metabolism...
Predicting the Effects of Anti-angiogenic Agents Targeting Specific VEGF Isoforms
The online version of this article (doi:10.1208/s12248-012-9363-4) contains supplementary material, which is available to authorized users.